The rising interest in GLP-1 agonists for diabetes has generated a debate about application forms : skin-applied devices versus tablets . Typically, GLP-1 therapies were only available in pill form, but the emergence of patches offers a different way. Skin applications might be advantageous for individuals with difficulty swallowing pills , thos… Read More